Rights and permissions
About this article
Cite this article
Liposomal doxorubicin + bevacizumab `surprisingly' toxic. React. Wkly. 1256, 4 (2009). https://doi.org/10.2165/00128415-200912560-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200912560-00013